Do You Need PGT-A Before Surrogacy? 2026 ASRM Insights
Introduction
As assisted reproduction continues to evolve, one question has become increasingly common among intended parents: whether genetic testing is necessary before embryo transfer. Specifically, many are asking if PGT-A is required before starting gestational surrogacy.
PGT-A, or preimplantation genetic testing for aneuploidy, screens embryos for chromosomal abnormalities. In the context of surrogacy in USA, where IVF plays a central role, this decision can affect success rates, costs, and timelines.
Guidance from the American Society for Reproductive Medicine in 2026 provides important insights into when PGT-A may be helpful—and when it may not be necessary.
What Is PGT-A and Why It Is Used
PGT-A is a laboratory test performed on embryos created through IVF. It helps identify whether an embryo has the correct number of chromosomes.
Clinics use PGT-A to:
• Reduce the risk of transferring abnormal embryos
• Improve implantation rates in certain cases
• Lower the chance of miscarriage
• Select embryos with higher developmental potential
Because most gestational surrogate mother arrangements involve IVF, PGT-A is often discussed during early planning.
What ASRM Says in 2026
The ASRM has taken a more nuanced position in recent years. Instead of recommending PGT-A for all patients, the organization emphasizes individualized decision making.
According to ASRM guidance:
• PGT-A may benefit patients with advanced maternal age
• It may help those with repeated IVF failure
• It is not necessary for every patient
• Evidence on universal use remains mixed
This means that intended parents pursuing surrogacy in US should not assume PGT-A is mandatory.
How PGT-A Fits Into Gestational Surrogacy
In gestational surrogacy, embryos are created before matching with a gestational surrogate or shortly after.
The process typically includes:
• Egg retrieval from intended mother or donor
• Fertilization and embryo development
• Optional PGT-A testing
• Embryo selection
• Transfer to the surrogate
Because embryo quality directly affects success rates, many clinics recommend testing in specific situations.
When PGT-A May Be Recommended
Medical professionals often suggest PGT-A in certain cases.
Common scenarios include:
• Intended mothers over age 35
• History of recurrent miscarriage
• Previously failed IVF cycles
• Known genetic concerns
• Limited number of embryos available
In these situations, testing may improve efficiency by selecting embryos more likely to succeed.
When PGT-A May Not Be Necessary
For some intended parents, PGT-A may not provide significant benefits.
Situations where testing may be optional include:
• Younger patients with strong ovarian reserve
• First time IVF cycles with no prior complications
• High quality embryos based on clinical evaluation
ASRM emphasizes that not all patients benefit equally from genetic screening.
Cost and Timeline Considerations
PGT-A adds both cost and time to the IVF process.
Typical considerations include:
• Additional lab fees for testing
• Delayed embryo transfer due to analysis
• Possible need for embryo freezing
In surrogacy in USA, where total costs are already high, this decision can affect overall budgeting.
Real World Clinical Perspective
Recent fertility clinic data suggests that while PGT-A can improve outcomes in certain populations, it does not guarantee success.
Studies referenced by ASRM show:
• Improved implantation rates in older patients
• Reduced miscarriage risk in specific cases
• No significant benefit in some younger populations
This reinforces the importance of individualized planning.
The Role of Surrogacy Agencies
Because PGT-A decisions affect both medical and logistical planning, agencies often help coordinate discussions between intended parents and clinics.
Professional agencies assist with:
• IVF timeline coordination
• Embryo transfer planning
• Matching with qualified surrogate mothers
• Ensuring compliance with surrogacy laws
Organizations such as Yunda Surrogacy guide intended parents through these decisions within the broader context of surrogacy in USA. Their experience helps families align medical recommendations with practical planning.
Legal and Ethical Considerations
While PGT-A is primarily a medical decision, it also raises ethical questions.
The ethics of surrogacy may include:
• Decisions about embryo selection
• Use of genetic information
• Balancing cost with medical benefit
Experts generally agree that when used responsibly, PGT-A can be part of an ethical and transparent surrogacy process.
How Location Can Influence Decisions
In major surrogacy hubs such as surrogate NYC, access to advanced fertility clinics often makes PGT-A more widely available.
However, availability does not mean necessity. Intended parents should rely on medical advice rather than location trends.
Frequently Asked Questions
Is PGT-A required for surrogacy
No. It is optional and depends on medical history and clinical recommendations.
Does PGT-A improve success rates
It may improve outcomes in certain cases, especially for older patients or those with prior IVF failure.
Is PGT-A common in the United States
Yes. It is widely available in surrogacy in US, but not universally required.
Conclusion
The question of whether to use PGT-A before surrogacy does not have a one size fits all answer. As 2026 guidance from ASRM suggests, the decision should be based on individual medical factors rather than routine practice.
For families pursuing gestational surrogacy, understanding the role of embryo testing helps balance cost, time, and success expectations. With proper medical guidance and coordinated support from experienced agencies like Yunda Surrogacy, intended parents can make informed choices that align with their goals.